Showing results (11-20 of 141) with videos related to
Sort By:
Pageof 15
Molecular Therapy. Nucleic Acids|September 2, 2015
Effective Small Interfering RNA Therapy to Treat CLCN7-dependent Autosomal Dominant Osteopetrosis Type 2Mattia Capulli, Antonio Maurizi, Luca Ventura, et al.Journal of Cellular Biochemistry|March 14, 2002
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV)Nadia Rucci, Silvia Migliaccio, Bianca Maria Zani, et al.Bone|March 5, 2018
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical developmentAntonio Maurizi, Mattia Capulli, Rajvi Patel, et al.Journal of Cell Science|July 15, 2005
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cellsNadia Rucci, Claudia DiGiacinto, Luigi Orrù, et al.International Journal of Molecular Sciences|January 21, 2022
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular DystrophyMarco Ponzetti, Argia Ucci, Antonio Maurizi, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 2, 2017
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to BoneAlfredo Cappariello, Alexander Loftus, Maurizio Muraca, et al.Bone Reports|May 24, 2021
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic womenAntonio Maurizi, Marco Ponzetti, Kaare M Gautvik, et al.Journal of Cellular Physiology|July 5, 2021
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in miceMarco Ponzetti, Federica Aielli, Argia Ucci, et al.Nature Communications|January 19, 2012
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signallingBarbara Peruzzi, Alfredo Cappariello, Andrea Del Fattore, et al.Biomaterials|February 14, 2015
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulationAlfredo Cappariello, Riccardo Paone, Antonio Maurizi, et al.Pageof 15